Faecal microbiota transplantation in 2013: developing human gut microbiota as a class of therapeutics

Nat Rev Gastroenterol Hepatol. 2014 Feb;11(2):79-80. doi: 10.1038/nrgastro.2013.231. Epub 2013 Dec 3.

Abstract

Although the idea of faecal transplantation dates back many decades, only with advances in scientific technologies can we begin systematic development of this new class of therapeutics. The primary focus remains on treatment of Clostridium difficile infection—new applications are beginning to emerge, but a long journey remains ahead.

Publication types

  • Review

MeSH terms

  • Anti-Bacterial Agents / adverse effects
  • Anti-Bacterial Agents / pharmacology
  • Clostridium Infections / therapy*
  • Feces / microbiology
  • Gastrointestinal Tract / microbiology*
  • Host-Pathogen Interactions / physiology
  • Humans
  • Microbiota / drug effects
  • Microbiota / physiology*
  • Therapeutics / trends*
  • Transplantation

Substances

  • Anti-Bacterial Agents